<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PI3K (<z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> 3-kinase) signalling pathways regulate a large array of cell biological functions in <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study we investigated the involvement of PI3K in modulating small molecule metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>A LC (liquid chromatography)-MS screen in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines isogenic for oncogenic PIK3CA mutations revealed an association between PI3K activation and the levels of <z:chebi fb="0" ids="51349">polyamine</z:chebi> pathway metabolites, including 5-methylthioadenosine, <z:chebi fb="0" ids="17148">putrescine</z:chebi> and <z:chebi fb="0" ids="16610">spermidine</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Pharmacological inhibition confirmed that the PI3K pathway controls <z:chebi fb="0" ids="51349">polyamine</z:chebi> production </plain></SENT>
<SENT sid="4" pm="."><plain>Despite inducing a decrease in PKB (protein kinase B)/Akt phosphorylation, <z:chebi fb="0" ids="16610">spermidine</z:chebi> promoted cell survival and opposed the anti-proliferative effects of PI3K inhibitors </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, <z:chebi fb="0" ids="51349">polyamine</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> by an <z:chebi fb="0" ids="18257">ornithine</z:chebi> decarboxylase inhibitor enhanced PKB/Akt phosphorylation, but suppressed cell survival </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that <z:chebi fb="0" ids="16610">spermidine</z:chebi> mediates cell proliferation and survival downstream of PI3K/Akt and indicate that these two biochemical pathways control each other's activities, highlighting a mechanism by which small molecule metabolism feeds back to regulate kinase signalling </plain></SENT>
<SENT sid="7" pm="."><plain>Consistent with this feedback loop having a functional role in these cell models, pharmacological inhibitors of PI3K and <z:chebi fb="0" ids="18257">ornithine</z:chebi> decarboxylase potentiated each other in inhibiting <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> in a <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The results of the present study support the notion that the modulation of <z:chebi fb="0" ids="16610">spermidine</z:chebi> concentrations may be a previously unrecognized mechanism by which PI3K sustains <z:hpo ids='HP_0011010'>chronic</z:hpo> proliferation of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
</text></document>